+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Severe hypercalcemic hyperparathyroidism developing in a patient with hyperaldosteronism and renal resistance to PTH



Severe hypercalcemic hyperparathyroidism developing in a patient with hyperaldosteronism and renal resistance to PTH







We evaluated an African American woman referred in 1986 at age 33 years because of renal potassium and calcium wasting and chronic hip pain. She presented normotensive, hypokalemic, hypocalcemic, normophosphatemic, and hypercalciuric. Marked hyperparathyroidism was evident. She excreted low amounts of urinary cAMP and did not increase the excretion rate in response to PTH infusion, indicating renal resistance to PTH. X-rays and bone biopsy revealed severe osteitis fibrosa cystica, confirming skeletal responsiveness to PTH. Renal potassium wasting, suppressed plasma renin activity, and elevated plasma and urinary aldosterone levels accompanied her hypokalemia, suggesting primary hyperaldosteronism. Hypokalemia resolved with spironolactone, and when combined with dietary sodium restriction, urinary calcium excretion fell and hypocalcemia improved, in accord with the known positive association between sodium intake and calcium excretion. Calcitriol and oral calcium supplements did not suppress the chronic hyperparathyroidism nor did they reduce aldosterone levels. Over time hyperparathyroid bone disease progressed with pathologic fractures and persistent pain. In 2004, PTH levels increased further in association with worsening chronic kidney disease. Eventually hypercalcemia and hypertension developed. Localizing studies in 2005 suggested a left inferior parathyroid tumor. After having consistently declined, the patient finally agreed to neck exploration in January, 2009. Four hyperplastic parathyroid glands were removed, followed immediately by severe hypocalcemia, attributed to hungry bone syndrome and hypoparathyroidism, which required prolonged hospitalization, calcium infusions and oral calcitriol. Although her bone pain resolved, hyperaldosteronism persisted.

(PDF emailed within 0-6 h: $19.90)

Accession: 036621598

Download citation: RISBibTeXText

DOI: 10.1002/jbmr.1791


Related references

Severe hypercalcemic hyperparathyroidism developing in a patient with hyperaldosteronism and renal resistance to parathyroid hormone. Journal of Bone and Mineral Research 28(3): 700-708, 2013

Case of severe hypercalcemic crisis in primary hyperparathyroidism. Vutreshni Bolesti 24(2): 106-109, 1985

Severe hyperkalaemia, hyperchloraemia, hyporeninaemia and hyperaldosteronism in a cyclosporin-treated renal-transplant patient. Nephrology, Dialysis, Transplantation 3(6): 826-829, 1988

Changes in blood pressure and renal function following subtotal parathyroidectomy in renal transplant patients presenting with persistent hypercalcemic hyperparathyroidism. Clinical Nephrology 47(4): 248-255, 1997

Changes in blood pressure and renal function after subtotal parathyroidectomy in renal transplant patients presenting persistent hypercalcemic hyperparathyroidism. Transplantation Proceedings 29(1-2): 204-206, 1997

Management of hypercalcemic hyperparathyroidism after renal transplantation. Archives of Surgery 120(5): 578-583, 1985

Successful percutaneous angioplasty of renal artery in a patient with severe arterial hypertension and symptoms of hyperaldosteronism: a case report. Kardiologia Polska 64(7): 724-6; Discussion 726-7, 2006

Severe primary hyperparathyroidism in a neonate with two hypercalcemic parents: management with parathyroidectomy and heterotopic autotransplantation. Pediatrics 78(2): 263-268, 1986

Hypercalcemic sarcoidosis and primary hyperparathyroidism disclosed by renal insufficiency. La Revue de Medecine Interne 5(3): 239-243, 1984

Sarcoidosis and primary hyperparathyroidism simultaneously occurring in a hypercalcemic patient. Indian Journal of Endocrinology and Metabolism 16(6): 1062-1063, 2012

Hypercalcemic crisis associated with anastrozole use in a patient with breast cancer and primary hyperparathyroidism. Endocrine 53(3): 868-869, 2016

Effect of cinacalcet on parathyroid hormone level in hypercalcemic hyperparathyroidism of patients with renal transplantation. Medicina Clinica 138(8): 323-326, 2012

Therapeutic failure of cinacalcet in a renal transplant patient presenting hyperparathyroidism with severe hypercalcaemia. Nephrology, Dialysis, Transplantation 20(12): 2865-2865, 2005

Coexisting tertiary hyperparathyroidism and severe hypothyroidism in an end-stage renal disease patient on hemodialysis. Nephro-Urology Monthly 7(2): E27191-E27191, 2015

Hyperparathyroidism in a renal transplant patient: an unusual cause of resistance to therapy. Bmj Case Reports 2012: -, 2014